COVID-19 Disruption of Trials is in Decline

Applied Clinical Trials

Most disruptions to clinical trials over the past three months were caused by the suspension of enrollment, followed by slow enrollment, and delayed initiation, says GlobalData, a data and analytics company. The number of disrupted trials began to fall between June and July. 

For more information, click here.